SCHEMBL150725

SCHEMBL150725

c1ccc([Se]c2ccccc2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BBOX1 O75936 4/20 0.60
EHMT2 Q96KQ7 4/20 0.60
EHMT1 Q9H9B1 4/20 0.60
ALDH1A1 P00352 4/20 0.40
MAOA P21397 1/20 0.36
TSHR P16473 4/20 0.35
ALOX12 P18054 3/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
CA12 O43570 1/20 0.35
GLA P06280 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA14 Q9ULX7 1/20 0.35
LMNA P02545 1/20 0.35
ACHE P22303 1/20 0.35
CA7 P43166 1/20 0.35
HPGD P15428 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3629169 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
Hydrochloric Acid SCHEMBL1157944 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
Bromide SCHEMBL31300172 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
SCHEMBL6477690 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
Bromide SCHEMBL9069066 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
Phosphine SCHEMBL14917741 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
Bromide SCHEMBL9069068 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
Hydrochloric Acid SCHEMBL30039649 0.96 BBOX1 (0.56) BBOX1EHMT2EHMT1ALDH1A1MAOA
Hydrochloric Acid SCHEMBL10533844 0.93 BBOX1 (0.53) BBOX1EHMT2EHMT1ALDH1A1MAOA
Hydrochloric Acid SCHEMBL10525049 0.93 BBOX1 (0.53) BBOX1EHMT2EHMT1ALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1018 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4282852-B1 METHOD FOR CHLORINATING AROMATIC COMPOUND HANWHA SOLUTIONS CORP (KR) 2025-09-17 EP claimed
CN-120166903-A Preparation method of photoactive layer of photovoltaic cell and photovoltaic cell 中国科学院长春应用化学研究所 2025-06-17 CN claimed
CN-119504718-A Natural schizophyllan component derivative DhpB and application thereof 南京中医药大学 2025-02-25 CN claimed
CN-118754063-A Nitrogen-doped carbon-coated CoSe with hollow structure prepared by solvothermal method2And sodium ion battery application thereof 武汉大学 2024-10-11 CN claimed
US-20240092712-A1 METHOD FOR CHLORINATING AROMATIC COMPOUND Hanwha Solutions Corporation (KR) 2024-03-21 US claimed
US-20240002328-A1 SELENIUM-BASED CATALYST SYSTEM FOR PREPARING CARBONATE DERIVATIVE, AND METHOD FOR PREPARING CARBONATE DERIVATIVE BY USING SAME KOREA INSTITUTE OF INDUSTRIAL TECHNOLOGY (KR) 2024-01-04 US claimed
CN-112002894-B Lithium supplementing material and preparation method and application thereof 松山湖材料实验室 2023-12-22 CN claimed
EP-4282852-A1 METHOD FOR CHLORINATING AROMATIC COMPOUND Hanwha Solutions Corporation (KR) 2023-11-29 EP claimed
CN-116897144-A Method for chlorinating aromatic compounds 韩华思路信株式会社 2023-10-17 CN claimed
CN-116002632-A Nitrogen-doped carbon-coated FeSe 2 Preparation method and application thereof 武汉大学 2023-04-25 CN claimed
EP-0574185-B1 PGE1 analogs NEWPHARMA INTERNATIONAL CORP (UY) 1997-09-03 EP claimed
WO-1997018215-A1 ANALOGUES OF N-ACETYLARDEEMIN, METHOD OF PREPARATION AND USES THEREOF SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) 1997-05-22 WO claimed
EP-0574185-A2 PGE1 analogs NEWPHARMA INTERNATIONAL CORPORATION (UY) 1993-12-15 EP claimed
WO-1991002975-A1 MULTIPLE-PROBE DIAGNOSTIC SENSOR THE BOARD OF REGENTS OF THE UNIVERSITY OF WASHINGTON (US) 1991-03-07 WO claimed
EP-0349060-A2 Process for the formation of 6-desmethyl-6-exo-methylene derivatives of lovastatin and analogs thereof MERCK & CO. INC. (US) 1990-01-03 EP claimed
US-4734518-A TRANSESTERIFICATION OF METHANOL AND ETHYLENE CARBONATE; GROUP V B OR VI B CATALYSTS TEXACO INC. (US) 1988-03-29 US claimed
EP-0153642-A2 Process for the preparation of monomeric aromatic hydroxyurethanes BAYER AG (DE) 1985-09-04 EP claimed
US-4308403-A FROM HYDROGEN, CARBON MONOXIDE, ALDEHYDE, ALCOHOL; COBALT COORDINATION CATALYST TEXACO INC. (US) 1981-12-29 US claimed
US-4115440-A PREPARATION OF ACRYLIC ACID OR METHACRYLIC ACID ATLANTIC RICHFIELD COMPANY (US) 1978-09-19 US claimed
US-4013730-A PROCESS FOR THE PREPARATION OF MONOCHLOROTOLUENE HOOKER CHEMICALS & PLASTICS CORPORATION (US) 1977-03-22 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002328-A1 SELENIUM-BASED CATALYST SYSTEM FOR PREPARING CARBONATE DERIVATIVE, AND METHOD FOR PREPARING CARBONATE DERIVATIVE BY USING SAME SELENOI, SCLY, SMOX BBOX1 912/4885EHMT2 405/4885EHMT1 393/4885
US-20240092712-A1 METHOD FOR CHLORINATING AROMATIC COMPOUND HDHD5, CBR3, CBR1 BBOX1 726/4885EHMT2 2969/4885EHMT1 3036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.